Professor Jennifer Martin
MBChB, MA (Oxon.), FRACP, PhD, GAICD
Search articles, podcasts and webinars on the MJA website.
Wiley Search is performed through the Wiley Online Library
Insight+ Search is performed through the insightplus.mja.com.au
3 Nov 2025
6 July 2026
3 August 2026
Rudi Louis Taylor-Bragge
Simon Rosenbaum, Grace McKeon, Gulsah Kurt, Oscar Lederman, Kemi Wright, Sabuj Kanti Mistry, Jackie E. Curtis, Philip B. Ward, Zachary Steel, Hamish Fibbins, Rachel Morell, Melissa C. Eaton, Andrew Watkins, Ben Harris-Roxas, Brendan Goodger, Eleanor Beck, Megan Teychenne, Joseph Firth, Davy Vancampfort, David Burns, Russell Roberts, Tristan Favaloro, Danielle Weber, Rosanna Barbero, Vasili Maroulis, Melissa Holmes, Stefan Mackenzie, Chiara Mastrogiovanni, Afsana Anwar, Uzma Choudhry, Catherine Sherrington, Jane Currie, Thomas Gadsden, Scott Teasdale
3 Nov 2025
6 July 2026
3 August 2026
Rudi Louis Taylor-Bragge
Simon Rosenbaum, Grace McKeon, Gulsah Kurt, Oscar Lederman, Kemi Wright, Sabuj Kanti Mistry, Jackie E. Curtis, Philip B. Ward, Zachary Steel, Hamish Fibbins, Rachel Morell, Melissa C. Eaton, Andrew Watkins, Ben Harris-Roxas, Brendan Goodger, Eleanor Beck, Megan Teychenne, Joseph Firth, Davy Vancampfort, David Burns, Russell Roberts, Tristan Favaloro, Danielle Weber, Rosanna Barbero, Vasili Maroulis, Melissa Holmes, Stefan Mackenzie, Chiara Mastrogiovanni, Afsana Anwar, Uzma Choudhry, Catherine Sherrington, Jane Currie, Thomas Gadsden, Scott Teasdale
View this article online at www.mja.com.au
MBChB, MA (Oxon.), FRACP, PhD, GAICD
Professor Jennifer Martin, clinical pharmacologist, educator and physician, is Director of the Centre for Drug Repurposing and Medicines Research and Chair Clinical Pharmacology in the School of Medicine and Public Health at the University of Newcastle, and is the Director of the NHMRC-funded Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), Australia's first federally-funded research centre in medicinal cannabinoids to ensure quality and safety in the implementation of medicinal cannabis use in the community. She leads the largest international medicinal cannabis trial, and first of its kind, enabling access to cannabis medicines for a significant advanced cancer population, and is part of Australia's first medical cannabis trial to produce world-class pharmacokinetic analysis and sophisticated modelling to inform drug dosage and frequency of administration. She also is Chief Investigator on Cancer Council NSW Pathways Program to develop a personalised chemotherapy dosing system for cancer patients and the lead pharmacology investigator for two current MRFF Programs.